RFL
Rafael Holdings, Inc.
Key Financials
Revenue
$917000
↑ 44.0%
Net Income
$-30520000
↓ 10424.1%
Operating Income
$-29159000
↑ 71.6%
Total Liabilities
$15.7M
↑ 48.8%
Cash & Equivalents
$52.8M
↑ 1872.7%
Total Assets
$114.1M
↑ 17.8%
EPS (Diluted)
$-1.04
↑ 28.3%
Shareholders' Equity
$94.4M
↑ 14.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RFL |
| Company Name | Rafael Holdings, Inc. |
| CIK | 1713863 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0731 |
| State of Incorporation | DE |
| Phone | 212-658-1450 |